Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
about
High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR.Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation.Current status of autologous stem cell transplantation in relapsed and refractory Hodgkin's lymphomaRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease.Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignanciesPrevalence of hematopoietic cell transplant survivors in the United States.Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine-based high-dose chemotherapy regimen.Hematopoietic cell transplantation for lymphomas.The role of hematopoietic SCT in adult Burkitt lymphoma.Is hematopoietic cell transplantation still a valid option for mantle cell lymphoma in first remission in the chemoimmunotherapy-era?Long-term complications after hematopoietic cell transplantation.Accelerated Total Lymphoid Irradiation-containing Salvage Regimen for Patients With Refractory and Relapsed Hodgkin Lymphoma: 20 Years of Experience.Cost-effectiveness analysis of consolidation with brentuximab vedotin for high-risk Hodgkin lymphoma after autologous stem cell transplantation.Spontaneous resolution of post-transplant localized cytomegalovirus lymphadenitis mimicking tumor recurrence.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantationRecommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.Conditional survival and excess mortality after high-dose therapy with autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation.The non-relapse mortality rate for patients with diffuse large B-cell lymphoma is greater than relapse mortality 8 years after autologous stem cell transplantation and is significantly higher than mortality rates of population controls.Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.Granulocyte colony-stimulating factor in secondary prophylaxis for advanced-stage Hodgkin lymphoma treated with ABVD chemotherapy: a cost-effectiveness analysis.Long-term clinical and molecular remissions in patients with mantle cell lymphoma following high-dose therapy and autologous stem cell transplantation.
P2860
Q34297698-E4CD2F09-2B9D-4E2A-B777-11B7CCFFD3B6Q35023409-7212B041-0603-4C7F-8128-EF6AF3BF7959Q35604039-5E50D534-23D2-49FB-94EC-C06532F661D4Q35705317-C5631096-0F92-4707-B2F8-009165B927FAQ35757247-300AC2E2-C002-4A43-A2C3-1311ACE42446Q36440055-D910D454-3619-4C6F-835B-C59196619DDAQ37180878-359795D0-D2FE-4E56-A614-DF40840D6473Q37188807-85A7CC72-B58E-4DD8-873D-8F054606C1CDQ37316657-D410A2A7-DB9B-48CB-9649-391498BC8801Q37942817-F117AF92-E3FB-4FAC-88C6-A4526A932384Q38031733-A5011885-DEFB-4BFE-97FF-F47EBAFEB57CQ38098877-F92D10CC-68D5-460A-B337-64A67D66CE32Q38667959-5375AEAC-8A53-40C5-A8BB-7866C45EA4E1Q39195424-5BF21C18-CEF4-4541-96E8-039F38B39ED8Q40149586-3F6267C8-9A95-47ED-A0F3-7637B34875B2Q40202358-512A0D6B-AFB4-43F9-B6A8-DC4CC0FE108EQ42111313-C80D15C6-1191-4015-8B54-B902BCF8ABA0Q42230889-CA80BBDB-E653-4D2F-979D-19A39B0A924AQ42847716-E0F49E07-BB27-4AB7-8E53-C109AF8F3877Q43218850-D7C02876-2388-435F-9D19-98B9354C02C5Q44595367-D61A5E5B-F66E-49D5-88E5-0F6D9BAF0E60Q45989594-FA41D828-FBC6-4000-9876-1BCFFFFD5248Q50892830-FFF7FE53-6E7E-44A2-BBB8-CFE645921B5EQ54231729-060F8E8F-E1DB-46F6-9A9D-54C656E337E5
P2860
Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@en
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@nl
type
label
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@en
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@nl
prefLabel
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@en
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@nl
P2093
P2860
P1476
Long-term survival and late re ...... gkin and non-Hodgkin lymphoma.
@en
P2093
J Douglas Rizzo
John P Klein
Mei-Jie Zhang
Navneet S Majhail
Ruta Bajorunaite
Zhiwei Wang
P2860
P304
P356
10.1111/J.1365-2141.2009.07798.X
P407
P577
2009-07-01T00:00:00Z